BridgeMD
A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
EU CTIS ID: 2023-506127-29-00
What this study is testing
To demonstrate that at least one dose of LY3556050 is superior to placebo in pain intensity.
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Are at least 18 years or older old at time of ICF signature.
- Have Type 1 Diabetes or Type 2 Diabetes for at least 6 months prior to screening.
- Have a stable glycemic control on stable diabetes treatment regimen for at least 90 days prior to day 1 of oral hypoglycemics medication.
- Are willing to discontinue all medications taken for chronic pain conditions.
- Are willing to abide by reproductive and contraceptive requirements.
You likely can't join if
- Have history of painful neuropathies other than DPNP
- Have symptomatic peripheral vascular disease.
- Have uncontrolled diabetes.
- Have a surgery planned.
- Have had cancer in past 2 years.
The study team makes the final eligibility decision.
Where it's taking place
- Japan
- United States
- Korea, Republic of
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Japan; United States; Korea, Republic of. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.